These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8901004)

  • 1. Arginine-aspartate and haloperidol-induced neurobehavioral effects in the rat.
    Patacchioli FR; Di Grezia R; Angelucci L
    Eur J Pharmacol; 1996 Mar; 299(1-3):29-32. PubMed ID: 8901004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol.
    Andersen HL; Kilpatrick IC
    Br J Pharmacol; 1996 May; 118(2):421-7. PubMed ID: 8735647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic mediation of beta-endorphin-induced catalepsy.
    Van Loon GR; Kim C
    Res Commun Chem Pathol Pharmacol; 1978 Jul; 21(1):37-44. PubMed ID: 567367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diminished catalepsy and dopamine metabolism distinguish aripiprazole from haloperidol or risperidone.
    Nakai S; Hirose T; Uwahodo Y; Imaoka T; Okazaki H; Miwa T; Nakai M; Yamada S; Dunn B; Burris KD; Molinoff PB; Tottori K; Altar CA; Kikuchi T
    Eur J Pharmacol; 2003 Jul; 472(1-2):89-97. PubMed ID: 12860477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis.
    Zetterström T; Sharp T; Ungerstedt U
    Eur J Pharmacol; 1984 Oct; 106(1):27-37. PubMed ID: 6085051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated testing of rats markedly enhances the duration of effects induced by haloperidol on treadmill locomotion, catalepsy, and a conditioned avoidance response.
    Hillegaart V; Ahlenius S; Magnusson O; Fowler CJ
    Pharmacol Biochem Behav; 1987 May; 27(1):159-64. PubMed ID: 3615537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide synthase inhibitors cause motor deficits in mice.
    Araki T; Mizutani H; Matsubara M; Imai Y; Mizugaki M; Itoyama Y
    Eur Neuropsychopharmacol; 2001 Apr; 11(2):125-33. PubMed ID: 11313158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of mecamylamine on the fate of dopamine in striatal and mesolimbic areas of rat brain; interaction with morphine and haloperidol.
    Ahtee L; Kaakkola S
    Br J Pharmacol; 1978 Feb; 62(2):213-8. PubMed ID: 564219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The enhancement of the hypomotility induced by small doses of haloperidol in the phase of dopaminergic supersensitivity in mice.
    Masuda Y; Murai S; Saito H; Abe E; Fujiwara H; Kohori I; Itoh T
    Neuropharmacology; 1991 Jan; 30(1):35-40. PubMed ID: 2046878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditional tolerance to haloperidol-induced catalepsy is not caused by striatal dopamine receptor supersensitivity.
    de Graaf CJ; Korf J
    Psychopharmacology (Berl); 1986; 90(1):54-7. PubMed ID: 3094062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle.
    Commissiong JW; Slimovitch C; Toffano G
    Br J Pharmacol; 1990 Apr; 99(4):741-9. PubMed ID: 2361171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MK 801 reverses haloperidol-induced catalepsy from both striatal and extrastriatal sites in the rat brain.
    Kaur S; Ozer H; Starr M
    Eur J Pharmacol; 1997 Aug; 332(2):153-60. PubMed ID: 9286616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clozapine-induced dopamine levels in the rat striatum and nucleus accumbens are not affected by muscarinic antagonism.
    Gray AM; Connick JH
    Eur J Pharmacol; 1998 Dec; 362(2-3):127-36. PubMed ID: 9874162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and chronic effects of neuroleptics and acute effects of apomorphine and amphetamine on dopamine turnover in corpus striatum and substantia nigra of the rat brain.
    Nicolaou NM
    Eur J Pharmacol; 1980 Jun; 64(2-3):123-32. PubMed ID: 6105080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain tyrosine depletion attenuates haloperidol-induced striatal dopamine release in vivo and augments haloperidol-induced catalepsy in the rat.
    Jaskiw GE; Bongiovanni R
    Psychopharmacology (Berl); 2004 Feb; 172(1):100-7. PubMed ID: 14586541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Substances that increase the extracellular level of dopamine in the striatum prevent development of haloperidol catalepsy in rats].
    Gaĭnetdinov RR; Raevskiĭ KS
    Biull Eksp Biol Med; 1996 Apr; 121(4):438-40. PubMed ID: 8829461
    [No Abstract]   [Full Text] [Related]  

  • 17. Nicotine potentiation of haloperidol-induced catalepsy: striatal mechanisms.
    Sanberg PR; Emerich DF; el-Etri MM; Shipley MT; Zanol MD; Cahill DW; Norman AB
    Pharmacol Biochem Behav; 1993 Oct; 46(2):303-7. PubMed ID: 8265684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ontogeny of tolerance to haloperidol: behavioral and biochemical measures.
    Coyle S; Napier TC; Breese GR
    Brain Res; 1985 Nov; 355(1):27-38. PubMed ID: 4075104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment.
    Nomura Y; Komori T; Okuda S; Segawa T
    Arch Int Pharmacodyn Ther; 1979 Jan; 237(1):25-30. PubMed ID: 485682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatodendritic and postsynaptic serotonin-1A receptors in the attenuation of haloperidol-induced catalepsy.
    Haleem DJ; Shireen E; Haleem MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1323-9. PubMed ID: 15588759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.